Table 3.

Clinical treatment and outcomes of pregnant and nonpregnant women with the coronavirus disease.

Variables			Total (N=43)	Pregnancy (n=17)	Nonpregnancy (n=26)	P value
Management, n (%)
	Antiviral therapy		38 (88)	13 (76)	25 (96)	.14
	Antibiotic therapy		36 (84)	13 (76)	23 (88)	.54
	Glucocorticoid therapy		9 (21)	4 (24)	5 (19)	.96
	Immunoglobulin		4 (9)	1 (6)	3 (12)	.93
	Cough-suppressant therapy		24 (56)	6 (35)	18 (70)	.03
	Oxygen support (nasal cannula)		20 (47)	6 (35)	14 (54)	.23
	Mechanical ventilation		0 (0)	0 (0)	0 (0)	N/Aa
		Noninvasive	0 (0)	0 (0)	0 (0)	N/A
		Invasive	0 (0)	0 (0)	0 (0)	N/A
	Continuous renal replacement therapy		0 (0)	0 (0)	0 (0)	N/A
	Extracorporeal membrane oxygenation		0 (0)	0 (0)	0 (0)	N/A
Clinical outcomes
	Intensive care unit admission, n (%)		0 (0)	0 (0)	0 (0)	N/A
	Acute respiratory distress syndrome, n (%)		0 (0)	0 (0)	0 (0)	N/A
	Disseminated intravascular coagulation, n (%)		0 (0)	0 (0)	0 (0)	N/A
	Renal failure, n (%)		0 (0)	0 (0)	0 (0)	N/A
	Heart failure, n (%)		0 (0)	0 (0)	0 (0)	N/A
	Secondary bacterial pneumonia, n (%)		0 (0)	0 (0)	0 (0)	N/A
	Sepsis, n (%)		0 (0)	0 (0)	0 (0)	N/A
	Death, n (%)		0 (0)	0 (0)	0 (0)	N/A
	Time of hospitalization (days), median (IQR)		22.0 (14.0-28.0)	17.0 (11.0-28.0)	22.0 (15.5-26.5)	.53
	Time from onset to diagnosis (days), median (IQR)		9.5 (6.3-17.0)	4.0 (2.0-17.0)	10.0 (7.5-17.0)	.09
	Time of viral shedding after onset of symptom (days), median (IQR)		25.0 (19.0-29.0)	24.0 (14.0-26.0)	26.0 (20.0-29.0)	.21
	Redetected positive for discharged patients, n/N (%)		2/30 (7)	2/11 (18)	2/19 (11)	.61

^aN/A: not applicable.